Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00467844 · ClinicalTrials.gov registry record · Phase 2
Study of GTx-024 on Muscle Wasting (Cachexia) Cancer.
A Phase 2 study, sponsored by GTx.
- Completed
- Registry status
- Phase 2
- Development phase
- 159
- Enrollment target
NCT00467844 is a Phase 2 study that has completed, run by GTx. The registered enrollment target is 159 participants.
The verdict
NCT00467844, a Phase 2 study, has completed, sponsored by GTx.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 159 participants
- Enrollment target
Study Summary
The purpose of this study is to assess if Gtx-024 is effective in increasing lean body mass in subjects with muscle wasting related to cancer.
Interventions
- DRUG Placebo
- DRUG GTx-024
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 159 participants |
| Start Date | 2007-05 |
| Est. Completion | 2008-09 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00467844
The ClinicalTrials.gov registry entry for NCT00467844 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 159 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is GTx, which has 15 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT00467844 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00467844 about?
NCT00467844 is a clinical study titled "Study of GTx-024 on Muscle Wasting (Cachexia) Cancer.". The purpose of this study is to assess if Gtx-024 is effective in increasing lean body mass in subjects with muscle wasting related to cancer.
What is the current status of trial NCT00467844?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 159 participants. The study started on 2007-05. Estimated completion is 2008-09.
What interventions are being tested in trial NCT00467844?
The interventions under investigation include: Placebo (DRUG), GTx-024 (DRUG).
Who is sponsoring clinical trial NCT00467844?
This trial is sponsored by GTx, which has 15 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.